Skip to content

Dietary Modulation of Hepatic Lipase (LIPC) -514 C/T Variant Associations With Lipids and Glucose

Hepatic Lipase Variant -514 C/T in a High Fat vs. Low Fat Diet for Cardio-metabolic Outcomes: A Crossover Randomized Dietary Intervention Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02938091
Enrollment
42
Registered
2016-10-19
Start date
2008-01-31
Completion date
2012-07-31
Last updated
2016-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia, Impaired Glucose Tolerance

Keywords

Hispanics, Single nucleotide polymorphism, Hepatic lipase

Brief summary

The investigators evaluated dietary modulation of LIPC rs1800588 (-514 C/T) for lipids and glucose using a randomized cross-over design comparing a high-fat Western diet and a low-fat traditional Hispanic diet in Caribbean Hispanics (n=42; 4 weeks/phase).

Detailed description

The LIPC -514 C/T single nucleotide polymorphism (SNP) has been inconsistently associated with high density lipoprotein cholesterol (HDL-C) in population studies, supporting the possibility of its modulation by dietary factors. To investigate the interaction between the common LIPC -514(C/T) SNP and dietary fat, the investigators compared changes in lipids and glucose in response to two levels of dietary total fat (20% energy intake vs. 39% energy intake) in a crossover, randomized dietary intervention study enrolling Caribbean Hispanics. Individuals were screened for LIPC rs1800588 genotype prior to enrollment, and genotype-associated differences in response to diet were evaluated. The study was designed to test the following hypotheses: 1. Carriers of the T allele consuming a low fat (LF) diet will have decreased hepatic lipase activity as compared with subjects with the CC genotype at the -514(C/T) polymorphism. Conversely, in individuals consuming a high fat (HF) diet, T carriers will exhibit an impaired ability to down regulate hepatic lipase activity. 2. Based on differences in hepatic lipase activity, the investigators hypothesized that a significant and clinically relevant proportion of the individual variability in fasting plasma HDL-C responses to changes in dietary fat intake would be due to variability at the LIPC locus. Specifically, CC subjects will respond to increases in total dietary fat consumption with significant increases in HDL-C concentration. Conversely, increased fat consumption in T carrying subjects will result in decreased HDL-C concentration.

Interventions

Typical Western diet

OTHERLow-fat diet

Traditional Caribbean Hispanic diet

Sponsors

Tufts University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Self-reported Caribbean Hispanics

Exclusion criteria

* diabetes * uncontrolled hypertension * self-reported liver disease; severe kidney dysfunction; angina; endocrine disease; preexisting cardiovascular disease or gallbladder disease, or pancreatitis within the past 12 months * use of lipid-lowering or hypoglycemic medications * BMI \>34 kg/m2 * alcohol consumption (\>2 drinks/day) * smoking within the past 6 months or illegal drug use * pregnancy or breastfeeding * weight gain or loss of more than 9 kg within the past 6 months * extreme levels of physical or athletic activity, strict vegetarians/vegans * egg, wheat, milk, fish, or nut allergies * unwillingness to discontinue fish oil or flaxseed supplements or drinking alcohol during the study * travel plans precluding availability for the two 4-week study phases

Design outcomes

Primary

MeasureTime frame
change in fasting high-density lipoprotein cholesterolFrom date of randomization until completion of each 4 week dietary intervention

Secondary

MeasureTime frame
change in fasting plasma triglyceridesFrom date of randomization until completion of the 4 week dietary intervention
change in fasting plasma glucoseFrom date of randomization until completion of the 4 week dietary intervention
oral glucose tolerance test2 hours post-oral glucose load
post-prandial lipemia 4 hours4 hours post-oral fat load
post-prandial lipemia 8 hours8 hours post-oral fat load

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026